4//SEC Filing
KASINGER JAMES R. 4
Accession 0000950170-25-041467
CIK 0001674416other
Filed
Mar 17, 8:00 PM ET
Accepted
Mar 18, 5:35 PM ET
Size
7.9 KB
Accession
0000950170-25-041467
Insider Transaction Report
Form 4
KASINGER JAMES R.
General Counsel and Secretary
Transactions
- Award
Restricted Stock Units
2025-03-14+27,500→ 27,500 total→ Common Shares (27,500 underlying) - Award
Stock Option (Right to Buy)
2025-03-14+36,666→ 36,666 totalExercise: $42.12Exp: 2035-03-14→ Common Shares (36,666 underlying)
Footnotes (3)
- [F1]This option was granted on March 14, 2025 with respect to 36,666 Common Shares. 100% of the shares will vest in 48 equal monthly installments, with the first vesting date of April 14, 2025.
- [F2]Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares.
- [F3]This restricted stock unit award was granted on March 14, 2025 with respect to 27,500 Common Shares, with (i) one quarter of the shares vesting on March 14, 2026, (ii) one quarter of the shares vesting on March 14, 2027, (iii) one quarter of the shares vesting on March 14, 2028, and (iv) one quarter of the shares vesting on March 14, 2029.
Documents
Issuer
CRISPR Therapeutics AG
CIK 0001674416
Entity typeother
Related Parties
1- filerCIK 0001708172
Filing Metadata
- Form type
- 4
- Filed
- Mar 17, 8:00 PM ET
- Accepted
- Mar 18, 5:35 PM ET
- Size
- 7.9 KB